Health
‘Stretched’ Vic hospital pleads for staff – Forbes Advocate
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection fro…
An Australian-first trial aims to “once and for all” settle the science surrounding an antimalarial drug touted by US President Donald Trump as protection from COVID-19.
The “COVID shield” study, led by Melbourne’s Walter and Eliza Hall Institute, has recruited more than 100 healthcare workers to test the efficacy of hydroxychloroquine.
Study co-lead Marc Pellegrini said half of study participants would be given the drug and the rest a placebo tablet over a four-month span to determine its eff…
-
Noosa News15 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News13 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News22 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common